[Natriuretic peptides in intensive care medicine].
Natriuretische Peptide in der Intensivmedizin.
BNP (B-type natriuretic peptide)
Cardiac function
Differential diagnosis
Fluid management
Laboratory diagnostics
NT-proBNP (N-terminal pro B‑type natriuretic peptide)
Journal
Medizinische Klinik, Intensivmedizin und Notfallmedizin
ISSN: 2193-6226
Titre abrégé: Med Klin Intensivmed Notfmed
Pays: Germany
ID NLM: 101575086
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
29
09
2022
accepted:
06
03
2023
revised:
18
01
2023
medline:
23
10
2023
pubmed:
26
4
2023
entrez:
26
4
2023
Statut:
ppublish
Résumé
Natriuretic peptides must be interpreted in their clinical context, especially in intensive care medicine. This overview presents the diagnostic, prognostic, and therapeutic significance of B‑type natriuretic peptide (BNP) and N‑terminal pro B‑type natriuretic peptide (NT-proBNP) in patients with cardiac dysfunction, kidney failure, sepsis, pulmonary embolism, acute respiratory distress syndrome (ARDS), acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and weaning from a respirator. Natriuretische Peptide müssen gerade in der Intensivmedizin in ihrem klinischen Kontext interpretiert werden. In dieser Übersicht wird die diagnostische, prognostische und therapeutische Bedeutung von BNP und NT-proBNP bei Patienten mit kardialer Dysfunktion, Nierenversagen, Sepsis, Lungenembolie, ARDS, AECOPD und im Weaning vom Respirator dargestellt.
Autres résumés
Type: Publisher
(ger)
Natriuretische Peptide müssen gerade in der Intensivmedizin in ihrem klinischen Kontext interpretiert werden. In dieser Übersicht wird die diagnostische, prognostische und therapeutische Bedeutung von BNP und NT-proBNP bei Patienten mit kardialer Dysfunktion, Nierenversagen, Sepsis, Lungenembolie, ARDS, AECOPD und im Weaning vom Respirator dargestellt.
Identifiants
pubmed: 37099150
doi: 10.1007/s00063-023-01002-1
pii: 10.1007/s00063-023-01002-1
doi:
Substances chimiques
Natriuretic Peptide, Brain
114471-18-0
Peptide Fragments
0
Biomarkers
0
Types de publication
English Abstract
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
527-533Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Références
Ammari Z, Al-Sarie M, Ea A et al (2021) Predictors of reduced cardiac index in patients with acute submassive pulmonary embolism. Catheter Cardiovasc Interv 97:292–298
pubmed: 32975377
doi: 10.1002/ccd.29269
Anwaruddin S, Lloyd-Jones DM, Baggish A et al (2006) Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP investigation of dyspnea in the emergency department (PRIDE) study. J Am Coll Cardiol 47:91–97
pubmed: 16386670
doi: 10.1016/j.jacc.2005.08.051
Booth J, Pinney J, Davenport A (2010) N‑terminal proBNP—marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 5:1036–1040
pubmed: 20507952
pmcid: 2879314
doi: 10.2215/CJN.09001209
Cavallazzi R, Nair A, Vasu T et al (2008) Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Med 34:2147–2156
pubmed: 18626627
doi: 10.1007/s00134-008-1214-5
de Cal M, Haapio M, Cruz DN et al (2011) B‑type natriuretic peptide in the critically ill with acute kidney injury. Int J Nephrol 2011:951629
pubmed: 21761002
pmcid: 3132842
Deschamps J, Andersen SK, Webber J et al (2020) Brain natriuretic peptide to predict successful liberation from mechanical ventilation in critically ill patients: a systematic review and meta-analysis. Crit Care 24:213
pubmed: 32393393
pmcid: 7216735
doi: 10.1186/s13054-020-2823-9
Ediboğlu Ö, Kıraklı C (2018) Can NT-pro BNP levels predict prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit? Balkan Med J 35:422–426
pubmed: 29966999
pmcid: 6251376
Feiz Disfani H, Lari S, Attaran D et al (2016) The early effectiveness of noninvasive positive pressure ventilation on right ventricular function in chronic obstructive pulmonary disease patients with acute hypercapnic respiratory failure. B23. Cardiovascular and respiratory interactions IN COPD. American Thoracic Society, S A2986
Hall C (2004) Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6:257–260
pubmed: 14987573
doi: 10.1016/j.ejheart.2003.12.015
Hartemink KJ, Twisk JW, Groeneveld AB (2011) High circulating N‑terminal pro-B-type natriuretic peptide is associated with greater systolic cardiac dysfunction and nonresponsiveness to fluids in septic vs nonseptic critically ill patients. J Crit Care 26:108.e1–108.e8
pubmed: 20646903
doi: 10.1016/j.jcrc.2010.05.002
Ikonomidis I, Nikolaou M, Dimopoulou I et al (2010) Association of left ventricular diastolic dysfunction with elevated Nt-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue doppler imaging parameters and Nt-pro-BNP Levels for adverse outcome. Shock 33:141–148
pubmed: 19487972
doi: 10.1097/SHK.0b013e3181ad31f8
Janssens U, Joannidis M (2016) Acute cardiorenal syndromes. Med Klin Intensivmed Notfmed 111:341–358
pubmed: 27165977
doi: 10.1007/s00063-016-0159-7
Jayasimhan D, Foster S, Chang CL et al (2021) Cardiac biomarkers in acute respiratory distress syndrome: a systematic review and meta-analysis. j intensive care 9:36
pubmed: 33902707
pmcid: 8072305
doi: 10.1186/s40560-021-00548-6
Karmpaliotis D, Kirtane AJ, Ruisi CP et al (2007) Diagnostic and prognostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest 131:964–971
pubmed: 17426196
doi: 10.1378/chest.06-1247
Kharasch ED, Yeo KT, Kenny MA et al (1988) Atrial natriuretic factor may mediate the renal effects of PEEP ventilation. Anesthesiology 69:862–869
pubmed: 2973759
doi: 10.1097/00000542-198812000-00010
Klouche K, Pommet S, Amigues L et al (2014) Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality. J Intensive Care Med 29:229–237
pubmed: 23753226
doi: 10.1177/0885066612471621
Komiya K, Akaba T, Kozaki Y et al (2017) A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema. Crit Care 21:228
pubmed: 28841896
pmcid: 6389074
doi: 10.1186/s13054-017-1809-8
Konstantinides SV, Meyer G, Becattini C et al (2020) 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J 41:543–603
pubmed: 31504429
doi: 10.1093/eurheartj/ehz405
Liu J, Wang CJ, Ran JH et al (2021) The predictive value of brain natriuretic peptide or N‑terminal pro-brain natriuretic peptide for weaning outcome in mechanical ventilation patients: evidence from SROC. J Renin Angiotensin Aldosterone Syst 22:1470320321999497
pubmed: 33678076
pmcid: 8880489
doi: 10.1177/1470320321999497
Luchner A, Weidemann A, Willenbrock R et al (2010) Improvement of the cardiac marker N‑terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial. Clin Chem Lab Med 48:121–128
pubmed: 20047532
doi: 10.1515/CCLM.2010.011
Madamanchi C, Alhosaini H, Sumida A et al (2014) Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol 176:611–617
pubmed: 25156856
pmcid: 4201035
doi: 10.1016/j.ijcard.2014.08.007
Maeder M, Fehr T, Rickli H et al (2006) Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129:1349–1366
pubmed: 16685029
doi: 10.1378/chest.129.5.1349
Mclean AS, Tang B, Nalos M et al (2003) Increased B‑type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 31:21–27
pubmed: 12635390
doi: 10.1177/0310057X0303100104
Mekontso Dessap A, Roche-Campo F, Kouatchet A et al (2012) Natriuretic peptide-driven fluid management during ventilator weaning: a randomized controlled trial. Am J Respir Crit Care Med 186:1256–1263
pubmed: 22997204
doi: 10.1164/rccm.201205-0939OC
Mekontso-Dessap A, de Prost N, Girou E et al (2006) B‑type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med 32:1529–1536
pubmed: 16941172
doi: 10.1007/s00134-006-0339-7
Mueller C, Mcdonald K, de Boer RA et al (2019) Heart failure association of the European society of cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail 21:715–731
pubmed: 31222929
doi: 10.1002/ejhf.1494
Noveanu M, Pargger H, Breidthardt T et al (2011) Use of B‑type natriuretic peptide in the management of hypoxaemic respiratory failure. Eur J Heart Fail 13:154–162
pubmed: 21036778
doi: 10.1093/eurjhf/hfq188
Ouellette DR, Patel S, Girard TD et al (2017) Liberation from mechanical ventilation in critically ill adults: an official American college of chest physicians/American thoracic society clinical practice guideline: inspiratory pressure augmentation during spontaneous breathing trials, protocols minimizing sedation, and noninvasive ventilation immediately after extubation. Chest 151:166–180
pubmed: 27818331
doi: 10.1016/j.chest.2016.10.036
Papanikolaou J, Makris D, Mpaka M et al (2014) New insights into the mechanisms involved in B‑type natriuretic peptide elevation and its prognostic value in septic patients. Crit Care 18:R94
pubmed: 24887309
pmcid: 4075117
doi: 10.1186/cc13864
Park S, Cho GY, Kim SG et al (2009) Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients. Crit Care 13:R70
pubmed: 19445682
pmcid: 2717430
doi: 10.1186/cc7878
Pirracchio R, Deye N, Lukaszewicz AC et al (2008) Impaired plasma B‑type natriuretic peptide clearance in human septic shock. Crit Care Med 36:2542–2546
pubmed: 18679125
doi: 10.1097/CCM.0b013e318183f067
Post F, Weilemann LS, Messow CM et al (2008) B‑type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Crit Care Med 36:3030–3037
pubmed: 18824903
doi: 10.1097/CCM.0b013e31818b9153
Ricci Z, Garisto C, Morelli S et al (2009) Brain natriuretic peptide is removed by continuous veno-venous hemofiltration in pediatric patients. Interact CardioVasc Thorac Surg 9:33–36
pubmed: 19339274
doi: 10.1510/icvts.2009.201848
Sawatani T, Shirakabe A, Okazaki H et al (2021) Clinical significance of the N‑terminal pro-brain natriuretic peptide and B‑type natriuretic peptide ratio in the acute phase of acute heart failure. Eur Heart J Acute Cardiovasc Care 10:1016–1026
pubmed: 34432003
doi: 10.1093/ehjacc/zuab068
Sevilla Berrios RA, O’horo JC, Velagapudi V et al (2014) Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: a systematic review and meta-analysis. J Crit Care 29:495–499
pubmed: 24746109
doi: 10.1016/j.jcrc.2014.03.007
Shor R, Rozenman Y, Bolshinsky A et al (2006) BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 17:536–540
pubmed: 17142170
doi: 10.1016/j.ejim.2006.07.013
Short PM, Anderson WJ, Elder DH et al (2015) Impact of left ventricular hypertrophy on survival in chronic obstructive pulmonary disease. Am J Physiol 193:487–495
Singh H, Ramai D, Patel H et al (2017) B‑type natriuretic peptide: a predictor for mortality, intensive care unit length of stay, and hospital length of stay in patients with resolving sepsis. Cardiol Res 8:271–275
pubmed: 29317968
pmcid: 5755657
doi: 10.14740/cr605w
Stolz D, Breidthardt T, Christ-Crain M et al (2008) Use of B‑type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest 133:1088–1094
pubmed: 18339792
doi: 10.1378/chest.07-1959
Sturgess DJ, Pascoe RL, Scalia G et al (2010) A comparison of transcutaneous Doppler corrected flow time, b‑type natriuretic peptide and central venous pressure as predictors of fluid responsiveness in septic shock: a preliminary evaluation. Anaesth Intensive Care 38:336–341
pubmed: 20369768
doi: 10.1177/0310057X1003800216
Tanabe Y, Obayashi T, Yamamoto T et al (2015) Predictive value of biomarkers for the prognosis of acute pulmonary embolism in Japanese patients: results of the Tokyo CCU network registry. J Cardiol 66:460–465
pubmed: 25843673
doi: 10.1016/j.jjcc.2015.03.002
Tulevski I, ten Wolde M, van Veldhuisen DJ et al (2007) Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol 116:161–166
pubmed: 16814410
doi: 10.1016/j.ijcard.2006.03.030
Vallabhajosyula S, Haddad TM, Sundaragiri PR et al (2018) Role of B‑type natriuretic peptide in predicting in-hospital outcomes in acute exacerbation of chronic obstructive pulmonary disease with preserved left ventricular function: a 5‑year retrospective analysis. J Intensive Care Med 33:635–644
pubmed: 27913775
doi: 10.1177/0885066616682232
Vallabhajosyula S, Wang Z, Murad MH et al (2020) Natriuretic peptides to predict short-term mortality in patients with sepsis: a systematic review and meta-analysis. Mayo Clin Proc Innov Qual Outcomes 4:50–64
pubmed: 32055771
pmcid: 7011015
doi: 10.1016/j.mayocpiqo.2019.10.008
Wu ZH, Tang Y, Zhao M et al (2021) Association between elevated brain natriuretic peptide levels and weaning failure: a systematic review and meta-analysis. Int J Clin Pract 75:e14850
pubmed: 34516015
doi: 10.1111/ijcp.14850